Team Cuban Card

The FDA has approved Yuvezzi as the first eye drop that combines two active ingredients – carbachol and brimonidine tartrate – to improve near vision without surgery.

Read the full paper: Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye

Editor’s note: This is a developing story. Please check back soon for updates. Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S. According to a press release from Tenpoint Therapeutics, patients can fill prescriptions from eye care professionals for Yuvezzi (carbachol 2.75%/brimonidine tartrate 0.1% ophthalmic solution) through the company’s e-pharmacy partner, PHILRx, as well as local retail pharmacies. Yuvezzi is the first FDA-approved eye drop that uses two active ingredients to improve visual acuity and depth of focus: carbachol, which constricts the iris

Editor’s note: This is a developing story. Please check back soon for updates. Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S. According to a press release from Tenpoint Therapeutics, patients can fill prescriptions from eye care professionals for Yuvezzi (carbachol 2.75%/brimonidine tartrate 0.1% ophthalmic solution) through the company’s e-pharmacy partner, PHILRx, as well as local retail pharmacies. Yuvezzi is the first FDA-approved eye drop that uses two active ingredients to improve visual acuity and depth of focus: carbachol, which constricts the iris

A 62-year-old man presented with unilateral glaucoma and darker heterochromia of the left iris, first documented 18 years previously. Best-corrected visual acuity was 20/40 and intraocular pressure was 32 mmHg despite brinzolamide/brimonidine and latanoprost/timolol therapy. Gonioscopy demonstrated an open angle to ciliary body band with scattered peripheral anterior synechiae, without mass lesion or posterior embryotoxon. Mild endothelial abnormalities and pupillary dilation raised concern for anterior segment dysgenesis or iridocorneal endothelial syndrome.

Anti glaucoma Drugs Commonly Used Typically medications are intended to reduce elevated intraocular pressure and prevent damage

AZAD Pharma developed its Brinzolamide Brimonidine Preservative-free eye drops suspension dossier with a clear goal for AZAD’s B2B customers: enable preservative-free eye care that supports microbiological integrity and easy, patient-friendly handling. To achieve this, AZAD chose Iridya®, Silgan Dispensing’s preservative‑free multidose dropper. The look, feel, and technology of the Iridya® system were decisive advantages compared with competing solutions.

Adrenergic (Sympathomimetic) Antiglaucoma Drugs - Brimonidine, Apraclonidine, Dipivefrin, and Epinephrine. Covers mechanism, uses, and side effects.

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss

Adrenergic antiglaucoma drugs are **sympathomimetic agents** used in the management of **glaucoma** , primarily by **reducing intraocular pressure (IOP)**. These drugs act by influencing **alpha-adrenergic receptors in the eye** , leading to **decreased aqueous humor production** and, in some cases, increased outflow. The most clinically relevant drugs in this group include **Brimonidine, Apraclonidine, Dipivefrin, and Epinephrine**. While newer agents are preferred today, understanding these drugs is essential for **pharmacology, ophthalmology, and nursing examinations**. ## Therapeutic and Pharmacologic Class These drugs are classified as: **1. Antiglaucoma agents** **2. Sympathomimetic (adrenergic) agents** They act mainly on **α-adrenergic receptors** in the ciliary body and ocular vasculature. ## Mechanism of Action (Core Concept) Adrenergic antiglaucoma drugs lower intraocular pressure primarily by: **1. Decreasing aqueous humor formation** from the ciliary body 2. In some cases, **increasing uveoscleral outflow** Alpha-2 selective agonists (like brimonidine and apraclonidine) reduce cyclic AMP levels in the ciliary epithelium, leading to reduced aqueous humor production. ## Brimonidine Brimonidine is a **selective alpha-2 adrenergic agonist** and is one of the **most commonly used drugs** in this class today. ### Mechanism of Action Brimonidine: * Decreases aqueous humor production * Increases uveoscleral outflow ### Therapeutic Uses Brimonidine is used in: * Chronic open-angle glaucoma * Ocular hypertension * Adjunct therapy with other antiglaucoma drugs ### Adverse Effects Common side effects include: * Dry mouth * Drowsiness and fatigue * Headache * Allergic conjunctivitis Because it can cross the blood–brain barrier, **CNS depression** may occur, especially in children and elderly patients. ## Apraclonidine Apraclonidine is also an **alpha-2 adrenergic agonist** , but it is **less selective** than brimonidine. ### Mechanism of Action Apraclonidine reduces: Aqueous humor production ### Therapeutic Uses Apraclonidine is mainly used: * For **short-term control of intraocular pressure** * To prevent **IOP spikes after laser eye surgery** It is **not preferred for long-term therapy** due to rapid tolerance (tachyphylaxis). ### Adverse Effects Side effects include: * Eye irritation * Allergic reactions * Dry mouth * Fatigue ## Dipivefrin Dipivefrin is a **prodrug of epinephrine** designed to improve ocular penetration and reduce systemic side effects. ### Mechanism of Action After conversion to epinephrine in the eye, dipivefrin: * Decreases aqueous humor production * Increases aqueous outflow ### Therapeutic Uses Dipivefrin was historically used in: Open-angle glaucoma However, it is now **rarely used** due to better alternatives. ### Adverse Effects Dipivefrin may cause: * Mydriasis * Eye irritation * Increased sensitivity to light * Systemic cardiovascular effects if absorbed ## Epinephrine Epinephrine is a **non-selective adrenergic agonist** with both alpha and beta activity. ### Mechanism of Action Epinephrine: * Reduces aqueous humor production * Increases outflow through trabecular meshwork ### Therapeutic Uses Epinephrine was used in: Chronic open-angle glaucoma Today, its use is limited due to **significant side effects**. ### Adverse Effects Epinephrine can cause: * Palpitations * Arrhythmias * Hypertension * Mydriasis and photophobia ## Adverse Reactions and Side Effects (Class Effects) ### Central Nervous System * Headache * Nervousness * Drowsiness ### Cardiovascular System * Palpitations * Arrhythmias * Hypertension (especially with systemic absorption) ### Eye, Ear, Nose, Throat (EENT) * Burning or stinging sensation * Eye pain * Sensitivity to light (photophobia) ## Important Nursing and Patient-Care Considerations Patients should be advised to: * Avoid activities requiring good visual acuity if mydriasis occurs * Expect possible light sensitivity * Report palpitations or dizziness immediately To reduce systemic absorption: * Instill drops into the **conjunctival sac** , not directly onto the eyeball * Apply **nasolacrimal duct pressure for at least 1 minute** after instillation ## Monitoring and Safety (“Make the Connection”) Healthcare providers should: * Monitor **intraocular pressure** regularly (tonometry) * Monitor **blood pressure, pulse, and heart rhythm** when therapy begins * Avoid concurrent use with **MAO inhibitors** , due to interaction risk ## Contraindications and Precautions Use with caution in patients with: * Cardiovascular disease * Hypertension * Arrhythmias * Depression or CNS disorders Alpha-2 agonists should be used carefully in **children** , as CNS depression can occur. ## Nursing Diagnosis (Exam-Relevant) Common nursing diagnoses include: * Disturbed sensory perception (visual) * Risk for injury related to visual disturbances and photophobia ## High-Yield Exam Pearls 1. Brimonidine is the **preferred alpha-2 agonist** for long-term glaucoma therapy. 2. Apraclonidine is mainly for **short-term use** and post-laser IOP spikes. 3. Dipivefrin is a **prodrug of epinephrine**. 4. All adrenergic antiglaucoma drugs primarily **decrease aqueous humor production**. ## Simple Mnemonic for Recall **“B-A-D-E” for Adrenergic Glaucoma Drugs** B – Brimonidine (most common) A – Apraclonidine (short-term) D – Dipivefrin (epinephrine prodrug) E – Epinephrine (older drug) ## FAQs on Adrenergic Antiglaucoma Drugs #### Which adrenergic drug is most commonly used today? Brimonidine is the most commonly used adrenergic antiglaucoma drug. #### Why is apraclonidine not used long-term? Because tolerance (tachyphylaxis) develops quickly. #### How do these drugs reduce intraocular pressure? By decreasing aqueous humor production and sometimes increasing outflow. #### Why apply pressure on the lacrimal duct after eye drops? To prevent systemic absorption and reduce side effects. #### Why are epinephrine and dipivefrin rarely used now? Due to cardiovascular side effects and availability of safer alternatives.

Simbrinza® (brinzolamide / brimonidine) - Case Name: Alcon Inc. v. Padagis Israel Pharms. Ltd., Civ. No. 22-1422-WCB, 2025 WL 457119 (D. Del....

Simbrinza® (brinzolamide / brimonidine) - Case Name: Alcon Inc. v. Padagis Israel Pharms. Ltd., Civ. No. 22-1422-WCB, 2025 WL 457119 (D. Del....